LU70985A1 - - Google Patents

Info

Publication number
LU70985A1
LU70985A1 LU70985A LU70985A LU70985A1 LU 70985 A1 LU70985 A1 LU 70985A1 LU 70985 A LU70985 A LU 70985A LU 70985 A LU70985 A LU 70985A LU 70985 A1 LU70985 A1 LU 70985A1
Authority
LU
Luxembourg
Application number
LU70985A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU70985A1 publication Critical patent/LU70985A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
LU70985A 1973-09-26 1974-09-24 LU70985A1 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732349024 DE2349024A1 (de) 1973-09-26 1973-09-26 6beta,7beta-epoxy-1alpha,2alphamethylen-d-homo-4-pregnen-3,20-dione

Publications (1)

Publication Number Publication Date
LU70985A1 true LU70985A1 (cg-RX-API-DMAC10.html) 1975-03-06

Family

ID=5894080

Family Applications (1)

Application Number Title Priority Date Filing Date
LU70985A LU70985A1 (cg-RX-API-DMAC10.html) 1973-09-26 1974-09-24

Country Status (16)

Country Link
US (1) US3965128A (cg-RX-API-DMAC10.html)
JP (1) JPS5059362A (cg-RX-API-DMAC10.html)
AR (1) AR202946A1 (cg-RX-API-DMAC10.html)
AU (1) AU7374074A (cg-RX-API-DMAC10.html)
BE (1) BE820381A (cg-RX-API-DMAC10.html)
DD (1) DD114599A5 (cg-RX-API-DMAC10.html)
DE (1) DE2349024A1 (cg-RX-API-DMAC10.html)
DK (1) DK507974A (cg-RX-API-DMAC10.html)
FI (1) FI280574A7 (cg-RX-API-DMAC10.html)
FR (1) FR2244492A1 (cg-RX-API-DMAC10.html)
IL (1) IL45629A0 (cg-RX-API-DMAC10.html)
LU (1) LU70985A1 (cg-RX-API-DMAC10.html)
NL (1) NL7412747A (cg-RX-API-DMAC10.html)
NO (1) NO743449L (cg-RX-API-DMAC10.html)
SE (1) SE7412058L (cg-RX-API-DMAC10.html)
ZA (1) ZA746131B (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999025703A1 (en) * 1997-11-14 1999-05-27 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
US6022890A (en) * 1997-11-14 2000-02-08 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
WO2006045096A2 (en) * 2004-10-20 2006-04-27 Resverlogix Corp. Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
CN101365446B (zh) * 2005-07-29 2013-05-22 雷斯弗洛吉克斯公司 预防和治疗复杂疾病的药物组合物及其经由可植入医药装置的递送
PL2118074T3 (pl) 2007-02-01 2014-06-30 Resverlogix Corp Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego
KR101629356B1 (ko) 2008-06-26 2016-06-13 리스버로직스 코퍼레이션 퀴나졸리논 유도체의 제조방법
JP5635535B2 (ja) 2009-01-08 2014-12-03 レスバーロジックス コーポレイション 心血管疾患の予防および治療のための化合物
WO2010106436A2 (en) 2009-03-18 2010-09-23 Resverlogix Corp. Novel anti-inflammatory agents
TR201818390T4 (tr) 2009-04-22 2019-01-21 Resverlogix Corp Yeni̇ anti̇-i̇nflamatuvar ajanlar
TR201909777T4 (tr) 2011-11-01 2019-07-22 Resverlogix Corp Sübsti̇tüe ki̇nazoli̇nonlara yöneli̇k oral çabuk salimli formülasyonlar
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
WO2014096965A2 (en) 2012-12-21 2014-06-26 Rvx Therapeutics Inc. Novel heterocyclic compounds as bromodomain inhibitors
US10111885B2 (en) 2015-03-13 2018-10-30 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases

Also Published As

Publication number Publication date
ZA746131B (en) 1975-09-24
JPS5059362A (cg-RX-API-DMAC10.html) 1975-05-22
US3965128A (en) 1976-06-22
SE7412058L (cg-RX-API-DMAC10.html) 1975-03-27
NO743449L (cg-RX-API-DMAC10.html) 1975-04-28
NL7412747A (nl) 1975-04-01
AR202946A1 (es) 1975-07-31
IL45629A0 (en) 1974-11-29
DE2349024A1 (de) 1975-04-10
FR2244492A1 (cg-RX-API-DMAC10.html) 1975-04-18
DD114599A5 (cg-RX-API-DMAC10.html) 1975-08-12
FI280574A7 (cg-RX-API-DMAC10.html) 1975-03-27
AU7374074A (en) 1976-04-01
DK507974A (cg-RX-API-DMAC10.html) 1975-06-09
BE820381A (fr) 1975-03-26

Similar Documents

Publication Publication Date Title
AU476761B2 (cg-RX-API-DMAC10.html)
AU465372B2 (cg-RX-API-DMAC10.html)
AU474593B2 (cg-RX-API-DMAC10.html)
AU474511B2 (cg-RX-API-DMAC10.html)
AU474838B2 (cg-RX-API-DMAC10.html)
AU471343B2 (cg-RX-API-DMAC10.html)
AU465453B2 (cg-RX-API-DMAC10.html)
AU465434B2 (cg-RX-API-DMAC10.html)
FI280574A7 (cg-RX-API-DMAC10.html)
AU450229B2 (cg-RX-API-DMAC10.html)
AU476714B2 (cg-RX-API-DMAC10.html)
AU472848B2 (cg-RX-API-DMAC10.html)
AU476696B2 (cg-RX-API-DMAC10.html)
AU461342B2 (cg-RX-API-DMAC10.html)
AR195311A1 (cg-RX-API-DMAC10.html)
AU471461B2 (cg-RX-API-DMAC10.html)
AR210729A1 (cg-RX-API-DMAC10.html)
AU476873B1 (cg-RX-API-DMAC10.html)
AU447540B2 (cg-RX-API-DMAC10.html)
AR193950A1 (cg-RX-API-DMAC10.html)
AU5288973A (cg-RX-API-DMAC10.html)
AU1891376A (cg-RX-API-DMAC10.html)
CH560998A5 (cg-RX-API-DMAC10.html)
BG22494A1 (cg-RX-API-DMAC10.html)
CH567791A5 (cg-RX-API-DMAC10.html)